000 | 01922 a2200505 4500 | ||
---|---|---|---|
005 | 20250518040647.0 | ||
264 | 0 | _c20200302 | |
008 | 202003s 0 0 eng d | ||
022 | _a1618-095X | ||
024 | 7 |
_a10.1016/j.phymed.2019.152931 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFan, Lu | |
245 | 0 | 0 |
_aEuphorbia factor L2 inhibits TGF-β-induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3. _h[electronic resource] |
260 |
_bPhytomedicine : international journal of phytotherapy and phytopharmacology _cSep 2019 |
||
300 |
_a152931 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
650 | 0 | 4 |
_aBenzoates _xpharmacology |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xdrug effects |
650 | 0 | 4 |
_aEuphorbia _xchemistry |
650 | 0 | 4 |
_aFused-Ring Compounds _xpharmacology |
650 | 0 | 4 | _aHep G2 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aMacrocyclic Compounds _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aPolycyclic Compounds _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
650 | 0 | 4 |
_aSTAT3 Transcription Factor _xmetabolism |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xmetabolism |
700 | 1 | _aZhu, Huayun | |
700 | 1 | _aTao, Weiwei | |
700 | 1 | _aLiu, Li | |
700 | 1 | _aShan, Xin | |
700 | 1 | _aZhao, Ming | |
700 | 1 | _aSun, Dongdong | |
773 | 0 |
_tPhytomedicine : international journal of phytotherapy and phytopharmacology _gvol. 62 _gp. 152931 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phymed.2019.152931 _zAvailable from publisher's website |
999 |
_c29686921 _d29686921 |